Quarterly report pursuant to Section 13 or 15(d)

STOCK BASED COMPENSATION (Tables)

v3.10.0.1
STOCK BASED COMPENSATION (Tables)
9 Months Ended
Aug. 31, 2018
Options Granted to Employees [Member]  
Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]
                      Fair Value at         
    No. of options     Exercise           grant     Expiration  
    granted     price     Vesting period     ( in thousands )     period  
Employee   50,000   $ 4.42     Quarterly over a
period of 1 year
  $ 163     10 years  
Employees   30,500   $ 8.91     Quarterly over a
period of 2 years
  $ 192     10 years  
Employee   250,000   $ 8.36     Semi-annual over a
period of 1 year
  $ 1,488     10 years  
MaSTherCell's
employees
  70,300   $ 8.43     Quarterly over a
period of 2 years
  $ 464     10 years  
MaSTherCell's
employees
  123,550   $ 8.43     Quarterly over a
period of 4 years
  $ 925     10 years  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  Nine Months Ended
  August 31, 2018
Value of one common share $4.42 - $8.85
Dividend yield 0%
Expected stock price volatility 97%- 91%
Risk free interest rate 2.96%- 2.11%
Expected term (years) 5 - 7
Options Granted to Non- Employees [Member]  
Schedule of Share-based Compensation, Stock Options Granted to Consultants [Table Text Block]
                      Fair value at        
    No. of options     Exercise           grant     Expiration  
    granted     price     Vesting period     ( in thousands )     period  
Non-employee   5,200     4.42     Over six months   $ 36     10 years  
Non-employee   13,725   $ 4.42,8.34     Immediately   $ 82     10 years  
Non-employee   8,333   $ 8.43     Annual over a period
of 5 year
  $ 57     10 years  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  Nine Months Ended
  August 31, 2018
Value of one common share $8.3,$4.42
Dividend yield 0%
Expected stock price volatility 91%- 98%
Risk free interest rate $2.33 -$2.83
Expected term (years) 4.5 - 10